Related Experiment Video
Updated: Jul 5, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
The association between atrial fibrillation and dementia: A UK linked electronic health records cohort study
Kieran Brooks1, Hiroyuki Yoshimura1, Arturo Gonzalez-Izquierdo1
1Institute of Health Informatics Research, University College London, London, UK.
Insights
Atrial fibrillation (AF) patients face a higher dementia risk, particularly vascular dementia (VaD), independent of stroke. Managing risk factors like stroke and diabetes is key to reducing dementia burden in AF patients.
Area of Science:
- Cardiology
- Neurology
- Epidemiology
Background:
- Investigated the association between atrial fibrillation (AF) and dementia, including subtypes like vascular dementia (VaD), Alzheimer's, and mixed dementia.
- Identified key predictors for dementia development in patients diagnosed with AF.
Purpose of the Study:
- To determine the risk of all-cause dementia and its subtypes in individuals with new-onset atrial fibrillation (AF).
- To identify specific risk factors that predict dementia development in AF patients.
Main Methods:
- Analysis of linked electronic health records for 183,610 new-onset AF patients and 367,220 controls in the UK (1998-2016).
- Utilized time-to-event analyses (Cox proportional hazards, weighted Cox) to assess dementia risk.
- Conducted sub-analyses considering stroke and age as factors.
Main Results:
- AF patients showed a significantly increased risk of all-cause dementia (HR=1.38) and vascular dementia (VaD) (HR=1.55).
- A significant association was found between AF and mixed dementia (HR=1.26), but not Alzheimer's or rare dementia forms.
- Strongest dementia predictors in AF patients included ischemic stroke, subarachnoid hemorrhage, intracerebral hemorrhage, and diabetes.
Conclusions:
- Atrial fibrillation (AF) is independently associated with an increased risk of dementia, especially VaD.
- Effective management and prevention of identified risk factors (stroke, diabetes) are crucial for mitigating dementia risk in AF patients.
Background:
We investigated the association between atrial fibrillation (AF) and dementia, and its subtypes (vascular-VaD, Alzheimer, mixed and rare dementia), and identified predictors for dementia in AF patients.
Methods:
The analysis was based on 183,610 patients with new-onset AF and 367,220 non-AF controls in the United Kingdom between 1998 and 2016, identified in three prospectively collected, linked electronic health records sources. Time-to-event (dementia or subtypes) analyses were performed using Cox proportional hazards and weighted Cox. Sub-analyses performed: including & censoring stroke and age (median used as cut-off).
Results:
Over a median follow-up of 2.67 years (IQR .65-6.02) for AF patients and 5.84 years for non-AF patients (IQR 2.26-11.80), incidence of dementia in the AF cohort was 2.65 per 100 person-years, compared to 2.02 in the non-AF cohort. After adjustment, a significant association was observed between AF and all-cause dementia (HR = 1.38, 95% CI: 1.31-1.45), driven by a strong association with VaD (HR = 1.55, 95% CI: 1.41-1.70). AF was also associated with mixed dementia (HR = 1.26, 95% CI: 1.01-1.56), but we could not confirm an association with Alzheimer (HR = 1.05, 95% CI: .94-1.16) and rare dementia forms (HR = 1.19, 95% CI: .90-1.56). Ischemic stroke (HR = 1.40, 95% CI: 1.26-1.56), subarachnoid haemorrhage (HR = 2.08, 95% CI: 1.47-2.96), intracerebral haemorrhage (HR = 1.95, 95% CI: 1.54-2.48) and diabetes (HR = 1.32, 95% CI: 1.24-1.41) were identified as the strongest predictors of dementia in AF patients.
Conclusions:
AF patients have an increased risk of dementia, independent of stroke, with highest risk of VaD. Management and prevention of the identified risk factors could be crucial to reduce the increasing burden of dementia.
More Related Videos
Related Concept Videos
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

